Anavex Life Sciences Corp (AVXL)

[Investor2014]

For what it is worth I am equally not tempted to buy into the Bryostatin-1 story, but granted they have only flopped two AD trials so far.

Best of luck with that too and hope for patients that one, both or all AD drug candidates one day becomes winners.

Now back to perusing the shiny bicycle catalogs just in case this is THE Christmas to beat them all!